CIK 0000316709 · Large accelerated filer
SCHWAB CHARLES CORP
Sign in to watch- Ticker
- SCHW
- Exchange
- NYSE
- Industry
- Security Brokers, Dealers & Flotation Companies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943025021
- Phone
- 817-859-5000
- Business address
- 3000 SCHWAB WAY, WESTLAKE, TX, 76262
Securities
- SCHW Charles Schwab Corporation (The) Common Stock NYSE
- SCHW-PD The Charles Schwab Corporation Depositary Shares each representing 1/40th interest in a share of 5.95% Non-Cumulative Perpetual Preferred Stock, Series D NYSE
- SCHW-PJ The Charles Schwab Corporation Depositary Shares, Each Representing a 1/40th Interest in a Share of 4.450% Non-Cumulative Perpetual Preferred Stock, Series J NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,957,188
- in 12 filings, $1.6M under 10b5-1 plans
Net −$69,957,188. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Schwab Charles R. −$39.0M Co-Chairman sold <1% of stake
- Bettinger Walter W −$28.2M Co-Chairman sold 29% of stake
- Hathi Neesha −$1.6M MD, Head Wealth Adv, Bnk, Tst sold 74% of stake
- Schwab-Pomerantz Carolyn −$1.0M Director sold <1% of stake
- Beatty Jonathan S −$111K MD, Head of Advisor Services sold 9% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-24 | Ellis Stephen A Director | Option exercise | +1,853 | $33.12 | $61K | 6,660 |
| 2025-06-24 | Ellis Stephen A Director | Option exercise · Nonqualified Stock Option (right to buy) | −1,853 | 0 | ||
| 2025-06-18 | Woolway Paul V MD, Chief Banking Officer | Option exercise 10b5-1 | +10,129 | $46.81 | $474K | 33,767 |
| 2025-06-18 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −10,129 | $90.01 | $912K | 39,154.11 |
| 2025-06-18 | Woolway Paul V MD, Chief Banking Officer | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −10,129 | 10,131 | ||
| 2025-06-18 | Murtagh Nigel J Chief Risk Officer | Option exercise 10b5-1 | +20,872 | $42.99 | $897K | 79,871.23 |
| 2025-06-18 | Murtagh Nigel J Chief Risk Officer | Sale 10b5-1 | −20,872 | $90.01 | $1.9M | 58,999.23 |
| 2025-06-18 | Murtagh Nigel J Chief Risk Officer | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −20,872 | 0 | ||
| 2025-06-05 | Schwab-Pomerantz Carolyn Director | Sale 10b5-1 | −14,400 | $87.25 | $1.3M | 1,505,998.66 |
| 2025-06-05 | Schwab-Pomerantz Carolyn Director | Sale 10b5-1 | −9,600 | $87.25 | $838K | 479,314 |
| 2025-06-03 | Verdeschi Michael D CFO | Shares withheld for taxes | −5,888 | $87.54 | $515K | 53,961 |
| 2025-06-02 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −3,290 | $87.68 | $288K | 39,154.11 |
| 2025-05-30 | Beatty Jonathan S MD, Head of Advisor Services | Sale | −2,850 | $87.57 | $250K | 15,219 |
| 2025-05-28 | Murtagh Nigel J Chief Risk Officer | Option exercise | +25,000 | $41.98 | $1.0M | 83,999.23 |
| 2025-05-28 | Murtagh Nigel J Chief Risk Officer | Sale | −25,000 | $88.20 | $2.2M | 58,999.23 |
| 2025-05-28 | Murtagh Nigel J Chief Risk Officer | Option exercise · Nonqualified Stock Option (right to buy) | −25,000 | 24,096 | ||
| 2025-05-27 | Schwab-Pomerantz Carolyn Director | Grant or award | +1,462 | 9,624 | ||
| 2025-05-27 | Schwab-Pomerantz Carolyn Director | Grant or award · Nonqualified Stock Option (right to buy) | +3,646 | 3,646 | ||
| 2025-05-27 | Brown Marianne Catherine Director | Grant or award | +1,462 | 15,751 | ||
| 2025-05-27 | Brown Marianne Catherine Director | Grant or award · Nonqualified Stock Option (right to buy) | +3,646 | 3,646 |
Page 17 of 22 · 422 trades